Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

KUMAR AMIT

2. Issuer Name and Ticker or Trading Symbol
Anixa Biosciences Inc [ANIX]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Chief Executive Officer

(Last)

(First)

(Middle)

C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250

3. Date of Earliest Transaction (Month/Day/Year)
09/20/2019

(Street)

SAN JOSE, CA 95118

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option

$ 0.67

09/20/2019

D⁽¹⁾

320,000

⁽²⁾

09/19/2022

Common Stock

320,000

⁽¹⁾

Employee Stock Option

$ 2.575

09/20/2019

A⁽¹⁾

320,000

⁽²⁾

09/19/2022

Common Stock

320,000

⁽¹⁾

320,000

Employee Stock Option

$ 0.67

09/20/2019

D⁽¹⁾

106,667

⁽³⁾

09/19/2022

Common Stock

106,667

⁽¹⁾

Employee Stock Option

$ 2.575

09/20/2019

A⁽¹⁾

106,667

⁽³⁾

09/19/2022

Common Stock

106,667

⁽¹⁾

106,667

Employee Stock Option

$ 0.67

09/20/2019

D⁽¹⁾

213,333

⁽³⁾

09/19/2022

Common Stock

213,333

⁽¹⁾

Employee Stock Option

$ 2.575

09/20/2019

A⁽¹⁾

213,333

⁽³⁾

09/19/2022

Common Stock

213,333

⁽¹⁾

213,333

Employee Stock Option

$ 0.67

09/20/2019

D⁽¹⁾

40,000

⁽⁴⁾

11/08/2023

Common Stock

40,000

⁽¹⁾

Employee Stock Option

$ 2.575

09/20/2019

A⁽¹⁾

40,000

⁽⁴⁾

11/08/2023

Common Stock

40,000

⁽¹⁾

40,000

Employee Stock Option

$ 0.67

09/20/2019

D⁽¹⁾

200,000

⁽⁵⁾

02/18/2026

Common Stock

200,000

⁽¹⁾

Employee Stock Option

$ 2.92

09/20/2019

A⁽¹⁾

200,000

⁽⁵⁾

02/18/2026

Common Stock

200,000

⁽¹⁾

200,000

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
KUMAR AMIT C/O ANIXA BIOSCIENCES, INC. 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE, CA 95118	X		Chief Executive Officer

Signatures

/s/ Amit Kumar		09/20/2019
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options.
(2)	The option was originally granted on September 19, 2012 and vested in 36 equal monthly installments beginning on October 31, 2012.
(3)	The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels.
(4)	The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013.
(5)	The option was originally granted on February 18, 2016 and vested in 36 consecutive monthly installments beginning on March 31, 2016.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.